Post-Rituximab Relapse Is Associated with Antinephrin Memory B Cells in Pediatric Patients with Idiopathic Nephrotic Syndrome (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO0426; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Conclusion The novel Fluorospot assay developed in our laboratory enables efficient enumeration of anti-nephrin memory B cells, which may help identify pediatric INS patients at risk of relapse following RTX treatment. Further studies are needed to assess its predictive value in identifying relapse risk before clinical recurrence."
Clinical • Glomerulonephritis • Nephrology • Pediatrics • Renal Disease
|
|
Manuela Colucci; Martina Riganati; Federica Zotta; Antonio Gargiulo; Andrea Angeletti; Gianluca Caridi; Xhuliana Kajana; Francesco Emma; Marina Vivarelli
|